News & AnalysisNucleix attracts $55mNucleix, a liquid biopsy company, has secured $55 million in funding.ByIris Dorbian7 April 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs